首页> 外文OA文献 >Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells

【2h】

Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells

机译：组蛋白脱乙酰酶抑制剂和Aurora激酶抑制剂在表达BCR-ABL的白血病细胞中的活性：HDAC和Aurora抑制剂在BCR-ABL表达的细胞中的组合

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Seiichi Okabe; Tetsuzo Tauchi; Yuko Tanaka; Shinya Kimura; Taira Maekawa; Kazuma Ohyashiki;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells [J] . Seiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, Cancer Cell International . 2013,第1期

机译：组蛋白脱乙酰酶抑制剂和Aurora激酶抑制剂在表达BCR-ABL的白血病细胞中的活性：HDAC和Aurora抑制剂在BCR-ABL表达的细胞中的组合
2. Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells [J] . Seiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, Cancer Cell International . 2013,第1期

机译：组蛋白脱乙酰酶抑制剂和Aurora激酶抑制剂在表达BCR-ABL的白血病细胞中的活性：HDAC和Aurora抑制剂在BCR-ABL表达的细胞中的组合
3. Gadd45a transcriptional induction elicited by the Aurora kinase inhibitor MK-0457 in Bcr-Abl-expressing cells is driven by Oct-1 transcription factor [J] . ManciniM., LeoE., AluigiM., Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 2012,第8期

机译：由Aur-1转录因子驱动Aurora激酶抑制剂MK-0457在表达Bcr-Abl的细胞中引起的Gadd45a转录诱导
4. THE NOVEL HDAC INHIBITOR HDAC-42 EXHIBITS BIOLOGIC ACTIVITY AGAINST MALIGNANT MAST CELL TUMORS THROUGH BOTH KIT AND HISTONE DEPENDENT PATHWAYS [C] . Tzu-Yin Lin, Sridhar Murahari, Sam Kulp, Annual Conference of the Veterinary Cancer Society . 2009

机译：新型HDAC抑制剂HDAC-42通过试剂盒和组蛋白依赖性途径对恶性肥大细胞肿瘤进行生物活性
5. The Molecular Mechanism of Histone Deacetylase (HDAC) Inhibitor PCI-24781 as an Anti-tumor Agent in Neuroblastoma Cells. [D] . Zhan, Qinglei. 2014

机译：组蛋白脱乙酰基酶（HDAC）抑制剂PCI-24781作为神经母细胞瘤细胞中抗肿瘤剂的分子机制。
6. Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells [O] . Seiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, 2013

机译：组蛋白脱乙酰酶抑制剂和Aurora激酶抑制剂在表达BCR-ABL的白血病细胞中的活性：HDAC和Aurora抑制剂在BCR-ABL表达的细胞中的组合
7. Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells [O] . Ellen Weisberg, Renee D. Wright, Douglas W. McMillin, 2008

机译：基质介导的酪氨酸激酶抑制剂处理的BCR-ABL表达白血病细胞

Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cells

著录项

相似文献

相关主题

期刊订阅